FOX
30
2
JPM
60
-2
WY
27
-7
MAT
50
18
BAC
44
-4
ILMN
36
10
LYB
32
2
BAX
41
3
WU
24
-6
XYL
43
-4
INTU
69
4
MDLZ
36
4
NTRS
39
2
ADM
36
2
SHW
61
2
AEE
46
11
AA
38
3
FIS
50
-3
DG
32
-2
MET
60
2
FOX
30
2
JPM
60
-2
WY
27
-7
MAT
50
18
BAC
44
-4
ILMN
36
10
LYB
32
2
BAX
41
3
WU
24
-6
XYL
43
-4
INTU
69
4
MDLZ
36
4
NTRS
39
2
ADM
36
2
SHW
61
2
AEE
46
11
AA
38
3
FIS
50
-3
DG
32
-2
MET
60
2
Financhill
Back

Deutsche Bank AG Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
47

DB
Deutsche Bank AG

Last Price:
15.48
Seasonality Move:
-1.25%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
47
Deutsche Bank AG (DB) is a Sell

Is Deutsche Bank AG a Buy, Sell or Hold?

  • The current Deutsche Bank AG [DB] share price is $15.47. The Score for DB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • DB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DB Stock Price Chart

What is Deutsche Bank AG's stock price today?

  • The Deutsche Bank AG share price today is $15.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DB is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

DB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 36.36 Sell
Chaikin Money Flow: -351077 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.91 - 16.95) Sell
Bollinger Bands (100): (13.84 - 16.82) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

DB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.76 Sell
20-day SMA: 16.3 Sell
50-day SMA: 16.49 Sell
200-day SMA: 13.6 Buy
8-day EMA: 15.82 Sell
20-day EMA: 16.16 Sell
50-day EMA: 16.15 Sell
200-day EMA: 14.2 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Deutsche Bank AG Earnings Growth & DB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.29 per share, and an increase next year of $0.57 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Deutsche Bank AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):